Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Burkitt Lymphoma 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia, Biphenotypic, Acute 7Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myeloid, Acute 3Down Syndrome 3Osteosarcoma 2Lymphoma, Mantle-Cell 2Urothelial Carcinoma of the Bladder 1Sarcoma, Ewing 1Rhabdoid Tumor 1Renal Pelvis and Ureter Urothelial Carcinoma 1Oropharyngeal Neoplasms 1Neoplasms 1Myeloproliferative Disorders 1Muscle Invasive Bladder Urothelial Carcinoma 1Mouth Neoplasms 1Meningeal Neoplasms 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Myeloid 1Leukemia, Mast-Cell 1Leukemia 1Laryngeal Neoplasms 1Hypopharyngeal Neoplasms 1Head and Neck Neoplasms 1GATA2 Deficiency 1Choroid Plexus Neoplasms 1Central Nervous System Neoplasms 1Carcinoma 1

Interventions

Temozolomide 4Cyclophosphamide 4X-Rays 3Vincristine 3Specimen Handling 3Phantoms, Imaging 3Magnetic Resonance Spectroscopy 3Ifosfamide 3Etoposide 3Doxorubicin 3ulixertinib 2tipifarnib 2selpercatinib 2ivosidenib 2cabozantinib 2Topotecan 2Radiation 2Nuclear Medicine Department, Hospital 2Irinotecan 2Congresses as Topic 2trifluridine tipiracil drug combination 1tazemetostat 1talazoparib 1palbociclib 1olaparib 1liposomal doxorubicin 1larotrectinib 1irinotecan sucrosofate 1ganitumab 1fludarabine phosphate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Ewing × Methotrexate × 30 days × Clear all
NCT07321912 2026-05-26

Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma

Milton S. Hershey Medical Center

Phase 2 Recruiting
406 enrolled
Sarcoma

Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡